Cardinal Health recently declared a quarterly dividend of US$0.5107 per share, payable on April 15, 2026, to shareholders of ...

Cardinal Health's analysis shows biosimilars are projected to strengthen cost savings and provider confidence across the healthcare ecosystem, with oncology rising in adoption and accessibility gains.

Shares of healthcare distributor and services company Cardinal Health (NYSE:CAH) jumped 10.1% in the afternoon session after the company reported better-than-expected fourth-quarter financial results ...

Cardinal Health’s at-Home Solutions business has benefited greatly from its acquisition of Advanced Diabetes Supply (ADS) in April 2025, but CEO Jason Hollar made a point during ...

Pharmaceutical distributor Cardinal Health is eyeing an expanded footprint in the specialty medicine space through the planned acquisitions of GI Alliance (GIA) and Advanced Diabetes Supply Group (DSG ...

In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.

The healthcare services specialist delivered a beat-and-raise quarter that morning. It posted some strong growth numbers in key fundamentals. 10 stocks we like better than Cardinal Health › One of the ...

Detailed price information for Palantir Technologies Inc Cl A (PLTR-Q) from The Globe and Mail including charting and trades.

Cardinal Health, which manufactures and distributes medical and laboratory products, has entered into a definitive agreement to acquire Integrated Oncology Network, a physician-led independent ...

Cardinal Health plans to buy two companies that will expand its diabetes and gastroenterology businesses as part of an overall strategy to grow its footprint in specialty medicine. The pharmaceuticals ...